Published in Electrophoresis on December 01, 2007
Reverse phase protein microarrays advance to use in clinical trials. Mol Oncol (2010) 1.23
Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society. Mol Cell Proteomics (2014) 1.11
A microfluidics assisted porous silicon array for optical label-free biochemical sensing. Biomicrofluidics (2011) 0.85
Post-genomics nanotechnology is gaining momentum: nanoproteomics and applications in life sciences. OMICS (2014) 0.77
Reverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical Use. Microarrays (Basel) (2015) 0.76
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
The human proteome project: current state and future direction. Mol Cell Proteomics (2011) 2.34
Free flow acoustophoresis: microfluidic-based mode of particle and cell separation. Anal Chem (2007) 2.22
Continuous separation of cells and particles in microfluidic systems. Chem Soc Rev (2010) 2.17
The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nat Biotechnol (2012) 2.14
Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev Cell (2004) 2.01
Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation. Mol Cell (2007) 1.70
Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy. Am J Med (2004) 1.67
Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry. PLoS One (2010) 1.58
Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol (2010) 1.55
Ultrasonic agitation in microchannels. Anal Bioanal Chem (2003) 1.53
Particle separation using ultrasound can radically reduce embolic load to brain after cardiac surgery. Ann Thorac Surg (2004) 1.50
Acoustic control of suspended particles in micro fluidic chips. Lab Chip (2004) 1.46
Continuous separation of lipid particles from erythrocytes by means of laminar flow and acoustic standing wave forces. Lab Chip (2004) 1.43
The AMPK-FoxO3A axis as a target for cancer treatment. Cell Cycle (2010) 1.42
Noninvasive acoustic cell trapping in a microfluidic perfusion system for online bioassays. Anal Chem (2007) 1.40
Structural variation on the short arm of the human Y chromosome: recurrent multigene deletions encompassing Amelogenin Y. Hum Mol Genet (2006) 1.36
Measuring the local pressure amplitude in microchannel acoustophoresis. Lab Chip (2010) 1.33
An LKB1 AT-AC intron mutation causes Peutz-Jeghers syndrome via splicing at noncanonical cryptic splice sites. Nat Struct Mol Biol (2004) 1.33
Activation of MyoD-dependent transcription by cdk9/cyclin T2. Oncogene (2002) 1.33
Differentiation-induced radioresistance in muscle cells. Mol Cell Biol (2004) 1.30
De novo balanced chromosome rearrangements in prenatal diagnosis. Prenat Diagn (2009) 1.29
Microfluidic, label-free enrichment of prostate cancer cells in blood based on acoustophoresis. Anal Chem (2012) 1.26
Microfluidic enzyme immunoassay using silicon microchip with immobilized antibodies and chemiluminescence detection. Anal Chem (2002) 1.26
Acoustofluidics 8: applications of acoustophoresis in continuous flow microsystems. Lab Chip (2012) 1.25
Standard guidelines for the chromosome-centric human proteome project. J Proteome Res (2012) 1.20
Separation of lipids from blood utilizing ultrasonic standing waves in microfluidic channels. Analyst (2004) 1.18
An automated on-line multidimensional HPLC system for protein and peptide mapping with integrated sample preparation. Anal Chem (2002) 1.17
Carrier medium exchange through ultrasonic particle switching in microfluidic channels. Anal Chem (2005) 1.17
Direct demonstration of tissue uptake of an inhaled drug: proof-of-principle study using matrix-assisted laser desorption ionization mass spectrometry imaging. Anal Chem (2011) 1.17
Developments for a growing Japanese patient population: facilitating new technologies for future health care. J Proteomics (2010) 1.15
A large interstitial deletion encompassing the amelogenin gene on the short arm of the Y chromosome. Hum Genet (2005) 1.13
Acoustic whole blood plasmapheresis chip for prostate specific antigen microarray diagnostics. Anal Chem (2009) 1.13
A homozygous frameshift mutation in the ESCO2 gene: evidence of intertissue and interindividual variation in Nmd efficiency. J Cell Physiol (2006) 1.09
In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects. BMC Genomics (2006) 1.08
Efficient removal of platelets from peripheral blood progenitor cell products using a novel micro-chip based acoustophoretic platform. PLoS One (2011) 1.08
Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging. J Proteomics (2011) 1.06
Signal-dependent regulation of gene expression as a target for cancer treatment: inhibiting p38alpha in colorectal tumors. Cancer Lett (2008) 1.06
Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma. Am J Respir Crit Care Med (2004) 1.05
Microfluidic biosensing systems. Part II. Monitoring the dynamic production of glucose and ethanol from microchip-immobilised yeast cells using enzymatic chemiluminescent micro-biosensors. Lab Chip (2004) 1.03
Acoustic radiation- and streaming-induced microparticle velocities determined by microparticle image velocimetry in an ultrasound symmetry plane. Phys Rev E Stat Nonlin Soft Matter Phys (2012) 1.03
Breakpoint determination of 15 large deletions in Peutz-Jeghers subjects. Hum Genet (2010) 1.02
Automated and temperature-controlled micro-PIV measurements enabling long-term-stable microchannel acoustophoresis characterization. Lab Chip (2011) 1.01
Transforming growth factor-beta 1 specifically induce proteins involved in the myofibroblast contractile apparatus. Mol Cell Proteomics (2004) 1.01
Inhibition of p38alpha unveils an AMPK-FoxO3A axis linking autophagy to cancer-specific metabolism. Autophagy (2009) 1.00
Two-hundredfold volume concentration of dilute cell and particle suspensions using chip integrated multistage acoustophoresis. Lab Chip (2012) 0.99
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer. Expert Rev Mol Diagn (2015) 0.98
Non-contact acoustic cell trapping in disposable glass capillaries. Lab Chip (2010) 0.98
Harmonic microchip acoustophoresis: a route to online raw milk sample precondition in protein and lipid content quality control. Anal Chem (2009) 0.97
Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndrome. Dig Dis Sci (2007) 0.96
Microfluidic biosensing systems. Part I. Development and optimisation of enzymatic chemiluminescent micro-biosensors based on silicon microchips. Lab Chip (2004) 0.95
MyoD recruits the cdk9/cyclin T2 complex on myogenic-genes regulatory regions. J Cell Physiol (2006) 0.95
Rapid proteome analysis of bronchoalveolar lavage samples of lifelong smokers and never-smokers by micro-scale liquid chromatography and mass spectrometry. Clin Chem (2006) 0.95
Pathological airway remodelling in inflammation. Clin Respir J (2010) 0.95
Integrated selective enrichment target--a microtechnology platform for matrix-assisted laser desorption/ionization-mass spectrometry applied on protein biomarkers in prostate diseases. Electrophoresis (2004) 0.94
Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms. J Proteomics (2010) 0.94
Developments in biobanking workflow standardization providing sample integrity and stability. J Proteomics (2013) 0.94
Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patients. PLoS One (2011) 0.94
p38alpha is required for ovarian cancer cell metabolism and survival. Int J Gynecol Cancer (2010) 0.93
Tumor-specific hyperactive low-molecular-weight cyclin E isoforms detection and characterization in non-metastatic colorectal tumors. Cancer Biol Ther (2006) 0.93
A novel AMPK-dependent FoxO3A-SIRT3 intramitochondrial complex sensing glucose levels. Cell Mol Life Sci (2013) 0.93
2DDB - a bioinformatics solution for analysis of quantitative proteomics data. BMC Bioinformatics (2006) 0.93
Duplication of 9 p11.2-p13.1: a benign cytogenetic variant. Prenat Diagn (2004) 0.92
Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation: a feasibility study. Proteomics (2002) 0.92
Bioelectrochemical studies of azurin and laccase confined in three-dimensional chips based on gold-modified nano-/microstructured silicon. Biosens Bioelectron (2009) 0.92
Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers. Clin Chem (2007) 0.92
Developments toward a microfluidic system for long-term monitoring of dynamic cellular events in immobilized human cells. Anal Chem (2004) 0.92
Blocking p38/ERK crosstalk affects colorectal cancer growth by inducing apoptosis in vitro and in preclinical mouse models. Cancer Lett (2012) 0.91
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers. J Proteomics (2010) 0.91
Biogrid--a microfluidic device for large-scale enzyme-free dissociation of stem cell aggregates. Lab Chip (2011) 0.90
Microchannel acoustophoresis does not impact survival or function of microglia, leukocytes or tumor cells. PLoS One (2013) 0.90
Four areas of engagement requiring strengthening in modern proteomics today. J Proteome Res (2014) 0.90
Biglycan isoforms with differences in polysaccharide substitution and core protein in human lung fibroblasts. Eur J Biochem (2002) 0.90
Biobank resources for future patient care: developments, principles and concepts. J Clin Bioinforma (2011) 0.90
Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation. Proteomics (2003) 0.90
Acoustic actuated fluorescence activated sorting of microparticles. Lab Chip (2014) 0.89
Blood plasma reference material: a global resource for proteomic research. J Proteome Res (2013) 0.89
Large scale biobanking of blood - the importance of high density sample processing procedures. J Proteomics (2012) 0.88
Ready-made matrix-assisted laser desorption/ionization target plates coated with thin matrix layer for automated sample deposition in high-density array format. Rapid Commun Mass Spectrom (2002) 0.88
Clinical protein science and bioanalytical mass spectrometry with an emphasis on lung cancer. Chem Rev (2010) 0.87
Semi-automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studies. Clin Transl Med (2015) 0.87
Seed particle-enabled acoustic trapping of bacteria and nanoparticles in continuous flow systems. Lab Chip (2012) 0.87
Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines. J Proteome Res (2013) 0.86
Nanocapillary liquid chromatography interfaced to tandem matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry: mapping the nuclear proteome of human fibroblasts. Electrophoresis (2003) 0.86
High-speed biomarker identification utilizing porous silicon nanovial arrays and MALDI-TOF mass spectrometry. Electrophoresis (2006) 0.86
Identification of novel candidate protein biomarkers for the post-polio syndrome - implications for diagnosis, neurodegeneration and neuroinflammation. J Proteomics (2008) 0.86
Improved performance in silicon enzyme microreactors obtained by homogeneous porous silicon carrier matrix. Talanta (2002) 0.86